Busting a Myth: Sodium-Glucose Cotransporter-2 Inhibitors do not Cause Postoperative Acute Kidney Injury.

2 However, implementation is insufficient despite the highly significant findings of these trials with SGLT-2is in CKD with statistically significant reductions in loss of kidney function, development of kidney failure, and mortality, as well as cardiovascular benefit, particularly in relation to hospitalisation for heart failure.

also in 132,142 other papers